searched by keywords and their combinations «neurofibromatosis type 1» with the words «skeletal

Перспективы эпигенетической терапии плоскоклеточного рака головы и шеиProspects of epigenetic therapy of head and neck squamous cell carcinoma

behavior or affective pathology. Therefore, we aimed to estimate a combined effect of PGS based on 30 SNPs

Роль мутаций в гене NF1 в спорадическом канцерогенезе for targeted therapy of both neurofibromatosis type 1 and sporadic neoplasms with mutations of this gene

targeted therapy

in the expression of miRNAs) and designing their targeted therapy using specific miRNAs as targets. This article

, it is necessary to develop an effective therapy for NF1. The effectiveness of complex therapy of NF1 with use

Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типа, a promising direction is NF1 therapy with STAT3 inhibitors and immune checkpoint inhibitors